SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Press Releases
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
October 21, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
October 17, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
October 16, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
October 10, 2025
 · 
3 min read
Press Releases
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
October 9, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
October 8, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
September 29, 2025
 · 
4 min read
Press Releases
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
September 29, 2025
 · 
6 min read
Press Releases
bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025
September 18, 2025
 · 
4 min read
Press Releases
Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules
September 10, 2025
 · 
5 min read
Load More
JOBS